| Fungal Infection |
0 |
0.99 |
| Skin and Soft Tissue Infection |
0 |
0.98 |
| Vulvovaginal Candidiasis |
0 |
1 |
| Candidiasis |
0 |
0.97 |
| Hospital |
0 |
0.44 |
| California |
0 |
0.22 |
| Candida |
0 |
0.96 |
| Mouth |
0 |
0.22 |
| Outpatient Clinic |
0 |
0.22 |
| Health Care Reform |
0 |
0.2 |
| Antifungal |
0 |
0.95 |
| Blood |
0 |
0.11 |
| Dermatophytosis |
0 |
0.11 |
| Estrogen |
0 |
0.11 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.11 |
| Pruritus |
0 |
0.11 |
| Refractory |
0 |
0.11 |
| Steroids |
0 |
0.11 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.1 |
| HIV Infection |
0 |
0.1 |